Hepatitis C Therapy

Hepatitis C Treatment
It is not what it used to be…..

“Treatment is recommended for all patients with acute or chronic HCV infection, except those with a short life expectancy that cannot be remediated by HCV therapy, liver transplantation, or another directed therapy.” ~Association for the Study of Liver Disease


The days of Interferon treatment are over. Medications for hepatitis C today can be as simple as one pill a day for 8 -12 weeks with minial or no side-effects. Caring Ambassadors encourages everyone to explore their option for treatment, make a plan with your health care team, then get rid of the virus!

The  major goals of  treatment for chronic hepatitis C are:

  • eliminate the virus from the body (cure!)
  • restore normal liver function (as shown by liver-specific blood tests)
  • prevent further liver damage (shown by improvement or stabilization on the liver biopsy or other non-invasive tests)
  • improve overall health and well-being

A sustained response is defined as continued undetectable HCV in the blood 12 weeks after the completion of treatment. At this point, a person is considered cured of chronic hepatitis C.1

Hep C Discussion Point™ is a tool designed by Caring Ambassadors medical experts that takes you through a series of questions about your hepatitis C experience. Once you’ve completed the questions, the program generates a customized list of topics, including the AASLD guidelines for your recommended treatment. You can print out and use as a guide in talking with your doctor about your hepatitis C health care. 

The treatment recommendations included in Hep C Discussion Point™  were developed by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. These guidelines, which the Caring Ambassadors Program strongly endorses, can be found at www.hcvguidelines.org.

1.Coppola N, De PS, Pisaturo M, Paradiso L, Macera M, Capoluongo N, et alSustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells. J Clin Virol. 2013;58(4):748-750.